Life-course blood pressure in relation to brain volumes

Alzheimer's and Dementia

Volumn 12, Issue 8, 2016, Pages 890-899

  Power, Melinda C ^a,b   Schneider, Andrea L C ^a,c   Wruck, Lisa ^d   Griswold, Michael ^e   Coker, Laura H ^f   Alonso, Alvaro ^g   Jack, Clifford R ^h   Knopman, David ^h   Mosley, Thomas H ⁱ   Gottesman, Rebecca F ^a,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h MAYO CLINIC   (United States)

ⁱ UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Blood pressure; Brain volumes; Cohort study; Epidemiology; Human; Hypertension; Hypotension; Magnetic resonance imaging; Neurodegeneration

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BRAIN SIZE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; PRIORITY JOURNAL; PULSE PRESSURE; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; AGE; AGING; ATHEROSCLEROSIS; BRAIN; DEMOGRAPHY; DIAGNOSTIC IMAGING; LONGITUDINAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ATHEROSCLEROSIS; BLOOD PRESSURE; BRAIN; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; UNITED STATES;

EID: 84969915302     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2016.03.012     Document Type: Article

References (32)

1. [1] Qiu, C., Winblad, B., Fratiglioni, L., The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4 (2005), 487–499.
2. [2] Gottesman, R.F., Schneider, A.L., Albert, M., Alonso, A., Bandeen-Roche, K., Coker, L., et al. Midlife Hypertension and 20-Year Cognitive Change: The Atherosclerosis Risk in Communities Neurocognitive Study. JAMA Neurol 71 (2014), 1218–1227.
3. [3] Power, M.C., Weuve, J., Gagne, J.J., McQueen, M., Viswanathan, A., Blacker, D., The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology 22 (2011), 646–659.
4. [4] Power, M.C., Tchetgen, E.J., Sparrow, D., Schwartz, J., Weisskopf, M.G., Blood pressure and cognition: factors that may account for their inconsistent association. Epidemiology 24 (2013), 886–893.
5. [5] Muller, M., Sigurdsson, S., Kjartansson, O., Aspelund, T., Lopez, O.L., Jonnson, P.V., et al. Joint effect of mid- and late-life blood pressure on the brain: The AGES-Reykjavik Study. Neurology 82 (2014), 2187–2195.
6. [6] Neuropathology Group Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357 (2001), 169–175.
7. [7] Davis, D.G., Schmitt, F.A., Wekstein, D.R., Markesbery, W.R., Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58 (1999), 376–388.
8. [8] Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7 (2011), 280–292.
9. [9] Dickerson, B.C., Stoub, T.R., Shah, R.C., Sperling, R.A., Killiany, R.J., Albert, M.S., et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76 (2011), 1395–1402.
10. [10] Jack, C.R. Jr., Wiste, H.J., Weigand, S.D., Rocca, W.A., Knopman, D.S., Mielke, M.M., et al. Age-specific population frequencies of cerebral beta-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study. Lancet Neurol 13 (2014), 997–1005.
11. [11] Robins, J.M., Hernan, M.A., Brumback, B., Marginal structural models and causal inference in epidemiology. Epidemiology 11 (2000), 550–560.
12. [12] Weuve, J., Tchetgen Tchetgen, E.J., Glymour, M.M., Beck, T.L., Aggarwal, N.T., Wilson, R.S., et al. Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology 23 (2012), 119–128.
13. [13] Hernan, M.A., Brumback, B., Robins, J.M., Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11 (2000), 561–570.
14. [14] Benjamini, Y., Hochberg, Y., Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Statist Soc Ser B (Methodological) 57 (1995), 289–300.
15. [15] Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 (1991), 239–259.
16. [16] Knopman, D.S., Mosley, T.H., Catellier, D.J., Sharrett, A.R., Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 65 (2005), 876–881.
17. [17] Knopman, D.S., Penman, A.D., Catellier, D.J., Coker, L.H., Shibata, D.K., Sharrett, A.R., et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology 76 (2011), 1879–1885.
18. [18] den Heijer, T., Launer, L.J., Prins, N.D., van Dijk, E.J., Vermeer, S.E., Hofman, A., et al. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 64 (2005), 263–267.
19. [19] den Heijer, T., van der Lijn, F., Ikram, A., Koudstaal, P.J., van der Lugt, A., Krestin, G.P., et al. Vascular risk factors, apolipoprotein E, and hippocampal decline on magnetic resonance imaging over a 10-year follow-up. Alzheimers Dement 8 (2012), 417–425.
20. [20] Swan, G.E., DeCarli, C., Miller, B.L., Reed, T., Wolf, P.A., Jack, L.M., et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 51 (1998), 986–993.
21. [21] Korf, E.S., White, L.R., Scheltens, P., Launer, L.J., Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 44 (2004), 29–34.
22. [22] DeCarli, C., Miller, B.L., Swan, G.E., Reed, T., Wolf, P.A., Garner, J., et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke 30 (1999), 529–536.
23. [23] Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J.J., Palumbo, C., et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 77 (2011), 461–468.
24. [24] Heijer, T., Skoog, I., Oudkerk, M., de Leeuw, F.E., de Groot, J.C., Hofman, A., et al. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging 24 (2003), 307–313.
25. [25] Strandgaard, S., Cerebral blood flow in the elderly: impact of hypertension and antihypertensive treatment. Cardiovasc Drugs Ther 4 Suppl 6 (1991), 1217–1221.
26. [26] Muller, M., van der Graaf, Y., Visseren, F.L., Mali, W.P., Geerlings, M.I., Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann Neurol 71 (2012), 825–833.
27. [27] Barry, D.I., Strandgaard, S., Graham, D.I., Braendstrup, O., Svendsen, U.G., Vorstrup, S., et al. Cerebral blood flow in rats with renal and spontaneous hypertension: resetting of the lower limit of autoregulation. J Cereb Blood Flow Metab 2 (1982), 347–353.
28. [28] Iadecola, C., Davisson, R.L., Hypertension and cerebrovascular dysfunction. Cell Metab 7 (2008), 476–484.
29. [29] Idiaquez, J., Roman, G.C., Autonomic dysfunction in neurodegenerative dementias. J Neurol Sci 305 (2011), 22–27.
30. [30] Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., Snyder, J.K., Sink, K.M., Rocco, M.V., et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 373 (2015), 2103–2116.
31. [31] Staessen, J.A., Thijs, L., Richart, T., Odili, A.N., Birkenhager, W.H., Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 57 (2011), e6–e7.
32. [32] Peters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 7 (2008), 683–689.